Free Trial
$100 Off Ends Tonight! MarketBeat All Access Returns to $249
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Save $100 Now
Claim MarketBeat All Access Sale Promotion

Bausch Health Companies (BHC) Competitors

Bausch Health Companies logo
C$7.72 +0.17 (+2.25%)
As of 04:00 PM Eastern

BHC vs. APHA, PBH, SLS, AUP, and CARA

Should you buy Bausch Health Companies stock or one of its competitors? MarketBeat compares Bausch Health Companies with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Bausch Health Companies include Aphria (APHA), Premium Brands (PBH), Solaris Resources (SLS), Aurinia Pharmaceuticals (AUP), and Cara Operations (CARA). These companies are all part of the "pharmaceutical products" industry.

How does Bausch Health Companies compare to Aphria?

Aphria (TSE:APHA) and Bausch Health Companies (TSE:BHC) are both mid-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, dividends, media sentiment, risk, valuation, profitability and analyst recommendations.

10.0% of Bausch Health Companies shares are owned by institutional investors. 11.3% of Bausch Health Companies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Aphria has a net margin of 0.00% compared to Bausch Health Companies' net margin of -13.54%. Bausch Health Companies' return on equity of 120.43% beat Aphria's return on equity.

Company Net Margins Return on Equity Return on Assets
AphriaN/A N/A N/A
Bausch Health Companies -13.54%120.43%4.16%

Given Aphria's higher probable upside, equities analysts clearly believe Aphria is more favorable than Bausch Health Companies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aphria
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Bausch Health Companies
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Bausch Health Companies has higher revenue and earnings than Aphria. Bausch Health Companies is trading at a lower price-to-earnings ratio than Aphria, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AphriaC$611.06M0.00-C$637.39M-C$2.01N/A
Bausch Health CompaniesC$10.53B0.27-C$125.65M-C$3.24N/A

In the previous week, Bausch Health Companies had 12 more articles in the media than Aphria. MarketBeat recorded 12 mentions for Bausch Health Companies and 0 mentions for Aphria. Aphria's average media sentiment score of 0.00 beat Bausch Health Companies' score of -0.25 indicating that Aphria is being referred to more favorably in the media.

Company Overall Sentiment
Aphria Neutral
Bausch Health Companies Neutral

Summary

Bausch Health Companies beats Aphria on 9 of the 13 factors compared between the two stocks.

How does Bausch Health Companies compare to Premium Brands?

Premium Brands (TSE:PBH) and Bausch Health Companies (TSE:BHC) are both mid-cap pharmaceutical products companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, valuation, media sentiment, earnings, analyst recommendations, profitability and risk.

In the previous week, Bausch Health Companies had 11 more articles in the media than Premium Brands. MarketBeat recorded 12 mentions for Bausch Health Companies and 1 mentions for Premium Brands. Premium Brands' average media sentiment score of 0.45 beat Bausch Health Companies' score of -0.25 indicating that Premium Brands is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Premium Brands
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Bausch Health Companies
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

32.8% of Premium Brands shares are held by institutional investors. Comparatively, 10.0% of Bausch Health Companies shares are held by institutional investors. 2.0% of Premium Brands shares are held by insiders. Comparatively, 11.3% of Bausch Health Companies shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Premium Brands has a beta of 0.801622, meaning that its stock price is 20% less volatile than the broader market. Comparatively, Bausch Health Companies has a beta of 0.631102, meaning that its stock price is 37% less volatile than the broader market.

Premium Brands presently has a consensus price target of C$118.62, indicating a potential upside of 30.00%. Given Premium Brands' stronger consensus rating and higher possible upside, analysts clearly believe Premium Brands is more favorable than Bausch Health Companies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Premium Brands
0 Sell rating(s)
1 Hold rating(s)
11 Buy rating(s)
1 Strong Buy rating(s)
3.00
Bausch Health Companies
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Premium Brands has a net margin of 0.52% compared to Bausch Health Companies' net margin of -13.54%. Bausch Health Companies' return on equity of 120.43% beat Premium Brands' return on equity.

Company Net Margins Return on Equity Return on Assets
Premium Brands0.52% 2.21% 3.61%
Bausch Health Companies -13.54%120.43%4.16%

Premium Brands has higher earnings, but lower revenue than Bausch Health Companies. Bausch Health Companies is trading at a lower price-to-earnings ratio than Premium Brands, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Premium BrandsC$7.88B0.60C$99.56MC$0.90101.38
Bausch Health CompaniesC$10.53B0.27-C$125.65M-C$3.24N/A

Summary

Premium Brands beats Bausch Health Companies on 12 of the 17 factors compared between the two stocks.

How does Bausch Health Companies compare to Solaris Resources?

Solaris Resources (TSE:SLS) and Bausch Health Companies (TSE:BHC) are both mid-cap pharmaceutical products companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, dividends, media sentiment, earnings, analyst recommendations, profitability and risk.

Solaris Resources has a net margin of 0.00% compared to Bausch Health Companies' net margin of -13.54%. Bausch Health Companies' return on equity of 120.43% beat Solaris Resources' return on equity.

Company Net Margins Return on Equity Return on Assets
Solaris ResourcesN/A 60.97% -51.67%
Bausch Health Companies -13.54%120.43%4.16%

In the previous week, Bausch Health Companies had 12 more articles in the media than Solaris Resources. MarketBeat recorded 12 mentions for Bausch Health Companies and 0 mentions for Solaris Resources. Solaris Resources' average media sentiment score of 0.00 beat Bausch Health Companies' score of -0.25 indicating that Solaris Resources is being referred to more favorably in the media.

Company Overall Sentiment
Solaris Resources Neutral
Bausch Health Companies Neutral

Solaris Resources presently has a consensus target price of C$19.50, suggesting a potential upside of 39.89%. Given Solaris Resources' stronger consensus rating and higher possible upside, equities research analysts plainly believe Solaris Resources is more favorable than Bausch Health Companies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Solaris Resources
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Bausch Health Companies
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Solaris Resources has a beta of 1.884686, suggesting that its share price is 88% more volatile than the broader market. Comparatively, Bausch Health Companies has a beta of 0.631102, suggesting that its share price is 37% less volatile than the broader market.

16.0% of Solaris Resources shares are held by institutional investors. Comparatively, 10.0% of Bausch Health Companies shares are held by institutional investors. 40.6% of Solaris Resources shares are held by company insiders. Comparatively, 11.3% of Bausch Health Companies shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Solaris Resources has higher earnings, but lower revenue than Bausch Health Companies. Solaris Resources is trading at a lower price-to-earnings ratio than Bausch Health Companies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Solaris ResourcesN/AN/A-C$46.49M-C$0.19N/A
Bausch Health CompaniesC$10.53B0.27-C$125.65M-C$3.24N/A

Summary

Solaris Resources beats Bausch Health Companies on 10 of the 15 factors compared between the two stocks.

How does Bausch Health Companies compare to Aurinia Pharmaceuticals?

Bausch Health Companies (TSE:BHC) and Aurinia Pharmaceuticals (TSE:AUP) are both mid-cap pharmaceutical products companies, but which is the better business? We will compare the two businesses based on the strength of their risk, earnings, media sentiment, profitability, dividends, valuation, analyst recommendations and institutional ownership.

10.0% of Bausch Health Companies shares are owned by institutional investors. 11.3% of Bausch Health Companies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, Bausch Health Companies had 12 more articles in the media than Aurinia Pharmaceuticals. MarketBeat recorded 12 mentions for Bausch Health Companies and 0 mentions for Aurinia Pharmaceuticals. Aurinia Pharmaceuticals' average media sentiment score of 0.00 beat Bausch Health Companies' score of -0.25 indicating that Aurinia Pharmaceuticals is being referred to more favorably in the news media.

Company Overall Sentiment
Bausch Health Companies Neutral
Aurinia Pharmaceuticals Neutral

Bausch Health Companies has higher revenue and earnings than Aurinia Pharmaceuticals. Bausch Health Companies is trading at a lower price-to-earnings ratio than Aurinia Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bausch Health CompaniesC$10.53B0.27-C$125.65M-C$3.24N/A
Aurinia PharmaceuticalsC$57.59M0.00-C$190.03M-C$1.48N/A

Given Aurinia Pharmaceuticals' higher possible upside, analysts plainly believe Aurinia Pharmaceuticals is more favorable than Bausch Health Companies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bausch Health Companies
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Aurinia Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Aurinia Pharmaceuticals has a net margin of 0.00% compared to Bausch Health Companies' net margin of -13.54%. Bausch Health Companies' return on equity of 120.43% beat Aurinia Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
Bausch Health Companies-13.54% 120.43% 4.16%
Aurinia Pharmaceuticals N/A N/A N/A

Summary

Bausch Health Companies beats Aurinia Pharmaceuticals on 9 of the 13 factors compared between the two stocks.

How does Bausch Health Companies compare to Cara Operations?

Bausch Health Companies (TSE:BHC) and Cara Operations (TSE:CARA) are both pharmaceutical products companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, media sentiment, risk, earnings, profitability, analyst recommendations and valuation.

10.0% of Bausch Health Companies shares are owned by institutional investors. 11.3% of Bausch Health Companies shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Cara Operations has lower revenue, but higher earnings than Bausch Health Companies.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bausch Health CompaniesC$10.53B0.27-C$125.65M-C$3.24N/A
Cara OperationsN/AN/AN/AN/AN/A

Cara Operations has a net margin of 0.00% compared to Bausch Health Companies' net margin of -13.54%. Bausch Health Companies' return on equity of 120.43% beat Cara Operations' return on equity.

Company Net Margins Return on Equity Return on Assets
Bausch Health Companies-13.54% 120.43% 4.16%
Cara Operations N/A N/A N/A

In the previous week, Bausch Health Companies had 11 more articles in the media than Cara Operations. MarketBeat recorded 12 mentions for Bausch Health Companies and 1 mentions for Cara Operations. Cara Operations' average media sentiment score of 0.00 beat Bausch Health Companies' score of -0.25 indicating that Cara Operations is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Bausch Health Companies
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Cara Operations
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Given Cara Operations' higher probable upside, analysts clearly believe Cara Operations is more favorable than Bausch Health Companies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bausch Health Companies
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Cara Operations
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

Bausch Health Companies beats Cara Operations on 7 of the 10 factors compared between the two stocks.

Get Bausch Health Companies News Delivered to You Automatically

Sign up to receive the latest news and ratings for BHC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BHC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BHC vs. The Competition

MetricBausch Health CompaniesDrug Manufacturers IndustryMedical SectorTSE Exchange
Market CapC$2.88BC$2.22BC$6.45BC$12.16B
Dividend Yield0.76%2.95%2.76%6.20%
P/E Ratio-2.385.1617.9337.64
Price / Sales0.271,770.59553.9211.68
Price / Cash7.7610.1843.4982.29
Price / Book-2.6410.6110.374.50
Net Income-C$125.65MC$20.70BC$3.57BC$299.09M
7 Day Performance3.35%5.88%6.01%1.38%
1 Month Performance0.39%3.71%3.52%1.46%
1 Year Performance26.14%23.05%34.13%55.45%

Bausch Health Companies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BHC
Bausch Health Companies
0.7284 of 5 stars
C$7.72
+2.3%
N/A+23.4%C$2.88BC$10.53BN/A19,900
APHA
Aphria
N/AN/AN/AN/AC$5.24BC$611.06MN/A1,200
PBH
Premium Brands
3.5688 of 5 stars
C$89.96
+1.1%
C$118.62
+31.9%
+12.2%C$4.68BC$7.88B99.96540
SLS
Solaris Resources
1.5077 of 5 stars
C$13.53
+4.5%
C$19.50
+44.1%
+113.8%C$2.26BN/AN/A10
AUP
Aurinia Pharmaceuticals
N/AN/AN/AN/AC$2.15BC$57.59MN/A300

Related Companies and Tools


This page (TSE:BHC) was last updated on 5/25/2026 by MarketBeat.com Staff.
From Our Partners